Literature DB >> 16687667

Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax.

Jetsumon Sattabongkot1, Nongnuch Yimamnuaychoke, Surasak Leelaudomlipi, Maneerat Rasameesoraj, Rachaneeporn Jenwithisuk, Russell E Coleman, Rachanee Udomsangpetch, Liwang Cui, Thomas G Brewer.   

Abstract

Our understanding of the biology of malaria parasite liver stages is limited because of the lack of efficient in vitro systems that support the exo-erythrocytic (EE) development of the parasite. We report the development of a new hepatocyte line (HC-04) from normal human liver cells. The HC-04 cells have proliferated in hormone-free medium for more than 200 passages. The cells were hyperdiploid, resembled liver parenchymal cells, and synthesized major liver-specific proteins and enzymes. Using Plasmodium falciparum and P. vivax sporozoites harvested from salivary glands of infected mosquitoes, we showed that HC-04 cells supported the complete EE development of these two most prevalent human malaria parasites. The EE parasites attained full maturation as shown by their infectivity to human erythrocytes. The infection rates of the liver cells were estimated to be 0.066% and 0.041% for P. falciparum and P. vivax, respectively. As the first human hepatocyte line known to support complete EE development of both P. falciparum and P. vivax, HC-04 will provide an experimental model that can be used for studying the biology of liver stage malaria parasites.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16687667

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  81 in total

Review 1.  Cross-species immunity in malaria vaccine development: two, three, or even four for the price of one?

Authors:  Bruno Douradinha; Maria M Mota; Adrian J F Luty; Robert W Sauerwein
Journal:  Infect Immun       Date:  2007-12-03       Impact factor: 3.441

Review 2.  A pre-emptive strike against malaria's stealthy hepatic forms.

Authors:  Dominique Mazier; Laurent Rénia; Georges Snounou
Journal:  Nat Rev Drug Discov       Date:  2009-11       Impact factor: 84.694

3.  Evaluation of the HC-04 cell line as an in vitro model for mechanistic assessment of changes in hepatic cytochrome P450 3A during adenovirus infection.

Authors:  Piyanuch Wonganan; Kristina Jonsson-Schmunk; Shellie M Callahan; Jin Huk Choi; Maria A Croyle
Journal:  Drug Metab Dispos       Date:  2014-04-24       Impact factor: 3.922

Review 4.  Susceptibility Testing of Medically Important Parasites.

Authors:  Abebe Genetu Bayih; Anjan Debnath; Edward Mitre; Christopher D Huston; Benoît Laleu; Didier Leroy; Benjamin Blasco; Brice Campo; Timothy N C Wells; Paul A Willis; Peter Sjö; Wesley C Van Voorhis; Dylan R Pillai
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

5.  Quantification of sporozoite invasion, migration, and development by microscopy and flow cytometry.

Authors:  Photini Sinnis; Patricia De La Vega; Alida Coppi; Urszula Krzych; Maria M Mota
Journal:  Methods Mol Biol       Date:  2013

Review 6.  Current therapies and future possibilities for drug development against liver-stage malaria.

Authors:  Rene Raphemot; Dora Posfai; Emily R Derbyshire
Journal:  J Clin Invest       Date:  2016-06-01       Impact factor: 14.808

7.  The crucial role of hepatocyte growth factor receptor during liver-stage infection is not conserved among Plasmodium species.

Authors:  Alexis Kaushansky; Stefan H I Kappe
Journal:  Nat Med       Date:  2011-10-11       Impact factor: 53.440

8.  Disruption of the Plasmodium falciparum liver-stage antigen-1 locus causes a differentiation defect in late liver-stage parasites.

Authors:  Sebastian A Mikolajczak; John B Sacci; Patricia De La Vega; Nelly Camargo; Kelly VanBuskirk; Urszula Krzych; Jun Cao; Marcelo Jacobs-Lorena; Alan F Cowman; Stefan H I Kappe
Journal:  Cell Microbiol       Date:  2011-06-24       Impact factor: 3.715

9.  Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design.

Authors:  Kelley M VanBuskirk; Matthew T O'Neill; Patricia De La Vega; Alexander G Maier; Urszula Krzych; Jack Williams; Megan G Dowler; John B Sacci; Niwat Kangwanrangsan; Takafumi Tsuboi; Norman M Kneteman; Donald G Heppner; Brant A Murdock; Sebastian A Mikolajczak; Ahmed S I Aly; Alan F Cowman; Stefan H I Kappe
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-22       Impact factor: 11.205

Review 10.  Antigens for pre-erythrocytic malaria vaccines: building on success.

Authors:  C Speake; P E Duffy
Journal:  Parasite Immunol       Date:  2009-09       Impact factor: 2.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.